scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1033037541 |
P356 | DOI | 10.1007/S10585-009-9272-9 |
P932 | PMC publication ID | 4136696 |
P698 | PubMed publication ID | 19517258 |
P50 | author | Bradford J. Wood | Q40114938 |
P2093 | author name string | Kent Hunter | |
Jennifer Shih | |||
Victor Frenkel | |||
Matthew R Dreher | |||
Nigel Crawford | |||
Claire B Pollock | |||
Hilary Hancock | |||
P2860 | cites work | The effects of shear stress and metastatic phenotype on the detachment of transformed cells | Q68031441 |
The influence of high-energy shock waves on the development of metastases | Q71475208 | ||
Role of extracellular matrix assembly in interstitial transport in solid tumors | Q73793048 | ||
Transcutaneous high-intensity focused ultrasonography can cure testicular cancer in solitary testis | Q83296679 | ||
Tumor metastasis: mechanistic insights and clinical challenges | Q29617676 | ||
Cell adhesion receptors in mechanotransduction | Q30438289 | ||
Investigations into pulsed high-intensity focused ultrasound-enhanced delivery: preliminary evidence for a novel mechanism. | Q30479437 | ||
Pulsed high-intensity focused ultrasound enhances apoptosis and growth inhibition of squamous cell carcinoma xenografts with proteasome inhibitor bortezomib. | Q30487871 | ||
Ultrasound mediated delivery of drugs and genes to solid tumors | Q30488681 | ||
Pulsed-high intensity focused ultrasound and low temperature-sensitive liposomes for enhanced targeted drug delivery and antitumor effect. | Q30493238 | ||
Pulsed high-intensity focused ultrasound enhances thrombolysis in an in vitro model | Q30494419 | ||
Dynamic mechanical response of elastic spherical inclusions to impulsive acoustic radiation force excitation | Q30499666 | ||
Rrp1b, a new candidate susceptibility gene for breast cancer progression and metastasis | Q33310470 | ||
MR-guided focused ultrasound surgery (MRgFUS) for the palliation of pain in patients with bone metastases--preliminary clinical experience | Q34572648 | ||
Murine osteosarcoma primary tumour growth and metastatic progression is maintained after marked suppression of serum insulin-like growth factor I. | Q34918405 | ||
Extracorporeal shockwave therapy: a review | Q34976830 | ||
Spatial and temporal control of expression of therapeutic genes using heat shock protein promoters | Q36009062 | ||
Potential role of pulsed-high intensity focused ultrasound in gene therapy | Q36429688 | ||
Cavitation bioeffects | Q36495811 | ||
Heparanase stimulation of protease expression implicates it as a master regulator of the aggressive tumor phenotype in myeloma | Q36973696 | ||
Targeting melanoma growth and metastasis with systemic delivery of liposome-incorporated protease-activated receptor-1 small interfering RNA. | Q37001800 | ||
Mechanotransduction - a field pulling together? | Q37289697 | ||
Laminin-332 is a substrate for hepsin, a protease associated with prostate cancer progression | Q39941224 | ||
Pulsed high-intensity focused ultrasound enhances uptake of radiolabeled monoclonal antibody to human epidermoid tumor in nude mice | Q40024514 | ||
The potential for enhancement of mouse melanoma metastasis by diagnostic and high-amplitude ultrasound | Q40257217 | ||
Pulsed high-intensity focused ultrasound enhances systemic administration of naked DNA in squamous cell carcinoma model: initial experience. | Q40441285 | ||
Contrast-aided diagnostic ultrasound does not enhance lung metastasis in a mouse melanoma tumor model. | Q40455843 | ||
Lithotripter shockwave-induced enhancement of mouse melanoma lung metastasis: dependence on cavitation nucleation. | Q40468773 | ||
Circulating tumor cells in patients with solid malignancy treated by high-intensity focused ultrasound | Q40560558 | ||
Preliminary experience using high intensity focused ultrasound for the treatment of patients with advanced stage renal malignancy | Q44666651 | ||
Response to sublethal heat treatment of prostatic tumor cells and of prostatic tumor infiltrating T-cells | Q44723823 | ||
Explant-cell culture of primary mammary tumors from MMTV-c-Myc transgenic mice | Q47388767 | ||
High-intensity focused ultrasound in the treatment of solid tumours | Q50250147 | ||
High-intensity focused ultrasound for the treatment of liver tumours | Q50250410 | ||
Radiation-force technique to monitor lesions during ultrasonic therapy. | Q50250499 | ||
Tumor growth reduction and DNA transfer by cavitation-enhanced high-intensity focused ultrasound in vivo | Q50250740 | ||
Influence of high-intensity focused ultrasound on the development of metastases. | Q50252965 | ||
P433 | issue | 7 | |
P921 | main subject | murine model | Q122890741 |
focused ultrasound | Q50333304 | ||
P304 | page(s) | 729-738 | |
P577 | publication date | 2009-06-11 | |
P1433 | published in | Clinical & Experimental Metastasis | Q13470030 |
P1476 | title | Evaluation of pulsed high intensity focused ultrasound exposures on metastasis in a murine model | |
P478 | volume | 26 |
Q30396581 | A new sensitizer DVDMS combined with multiple focused ultrasound treatments: an effective antitumor strategy |
Q38612537 | Drug-Loaded Perfluorocarbon Nanodroplets for Ultrasound-Mediated Drug Delivery |
Q64986371 | High-intensity focused ultrasound inhibits invasion and metastasis of colon cancer cells by enhancing microRNA-124-mediated suppression of STAT3. |
Q47218227 | Histotripsy of renal implanted VX-2 tumor in a rabbit model: investigation of metastases |
Q36171653 | Infection dynamics and response to chemotherapy in a rabbit model of tuberculosis using [¹⁸F]2-fluoro-deoxy-D-glucose positron emission tomography and computed tomography |
Q38392481 | Mechanical high-intensity focused ultrasound destruction of soft tissue: working mechanisms and physiologic effects |
Q30466278 | Phase-shift, stimuli-responsive drug carriers for targeted delivery |
Q30450131 | Phase-shift, stimuli-responsive perfluorocarbon nanodroplets for drug delivery to cancer |
Q28488824 | Potentiation of scutellarin on human tongue carcinoma xenograft by low-intensity ultrasound |
Q64084792 | Spatially Specific Liposomal Cancer Therapy Triggered by Clinical External Sources of Energy |
Q37821902 | Ultrasound-based combination therapy: potential in urologic cancer |
Search more.